MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Tandem Diabetes Care Operating Income 2011-2026 | TNDM
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.29 M | -581 K | -233 M | -92.8 M | 22.7 M | -7.96 M | -16.7 M | -44.6 M | -62.9 M | -78.1 M | -69 M | -75.7 M | -49.4 M | -33 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.7 M | -233 M | -52.4 M |
Quarterly Operating Income Tandem Diabetes Care
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.9 M | -51.8 M | -121 M | - | -26.1 M | -30.8 M | -41.7 M | - | -31.5 M | -38.8 M | -128 M | - | -47.5 M | -12.2 M | -15.3 M | 12.7 M | 7.72 M | 5.43 M | -3.24 M | 18.7 M | -1.01 M | -12 M | -13.6 M | 2.14 M | -6 M | -1.86 M | -11 M | 560 K | -15.7 M | -14 M | -15.5 M | -9.58 M | -13.2 M | -19 M | -21.2 M | -13.3 M | -28.4 M | -17.1 M | -19.2 M | -11.2 M | -18.7 M | -18.7 M | -20.4 M | -17.5 M | -19 M | -18.3 M | -20.8 M | -16.5 M | -12.1 M | -13.7 M | -7.17 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.7 M | -128 M | -19.8 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bruker Corporation
BRKR
|
253 M | $ 36.74 | - | $ 5.47 K |  USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 9.38 | - | $ 266 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.59 | - | $ 36.7 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.07 | - | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.7 | - | $ 347 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-19.8 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 81.19 | - | $ 47.5 B | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.6 | - | $ 122 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 88.6 | - | $ 12 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.9 | - | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.31 | - | $ 717 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 54.14 | - | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.0 | - | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 85.63 | - | $ 2.97 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.94 | - | $ 374 M | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.89 | -2.81 % | $ 70.4 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Medtronic PLC
MDT
|
5.96 B | $ 86.28 | - | $ 111 B | USA |
 |
Align Technology
ALGN
|
608 M | $ 171.87 | - | $ 12.9 B | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.7 | - | $ 29.3 M | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 32.64 | - | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 11.77 | - | $ 466 M |  Curacao |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Penumbra
PEN
|
189 M | $ 329.87 | - | $ 12.8 B | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Insulet Corporation
PODD
|
474 M | $ 203.5 | - | $ 14.3 B | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.53 | 0.4 % | $ 7.02 M | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.13 | -0.24 % | $ 874 M | USA |
 |
Smith & Nephew plc
SNN
|
593 M | $ 32.63 | - | $ 23.8 B |  Britain |
 |
Stryker Corporation
SYK
|
4.89 B | $ 332.3 | - | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
29.3 M | $ 24.57 | - | $ 562 M | USA |
 |
TELA Bio
TELA
|
-33.8 M | $ 0.63 | 5.47 % | $ 29.6 M | USA |
 |
TransMedics Group
TMDX
|
109 M | $ 104.8 | - | $ 3.56 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |